AMZN
Amazon.com, Inc.
AMZN has the edge over MTH overall, supported by stronger valuation and stronger modeled upside.
MTH
Meritage Homes Corporation
MTH trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MTH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Unavailable | |
| Under pressure |
MTH's profitability is currently stable, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MTH in the historical PE scenario, which offers more potential upside but is not a forecast.
MTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.8x | $21.55 | -67% |
| Fair | 7.7x | $34.14 | -47% |
| Expensive | 11x | $46.91 | -28% |
| Current | 15x | $64.80 | — |
| Forward | 16x | $64.80 | — |
Historical ranges are pointers, not guarantees.
MTH's PE is in its expensive range at 15x. Analysts expect earnings to fall, which would put today's price at 16x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over MTH on the outlook, with more favorable earnings and revenue expectations.
MTH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect MTH's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MTH on earnings, with more consistent year-over-year improvement.
MTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.93 | -12% |
| Q3 2026 | $4.46 | -40% |
| Q2 2026 | $4.81 | -45% |
| Q1 2026 | $5.48 | -45% |
| Q4 2025 | $6.35 | -41% |
| Q3 2025 | $7.49 | -32% |
| Q2 2025 | $8.77 | -23% |
| Q1 2025 | $9.88 | -7.8% |
| Q4 2024 | $10.72 | +7.6% |
MTH's earnings per share have fallen from their peak: $4.46 over the past year, against $13.37 in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
MTH Quarterly Revenue
MTH and AMZN do not have enough comparable growth data to identify a winner.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 23% | N/A |
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$35.3M | +$69M |
| Q2 2026 | $183.9M | +2552% |
| Q1 2026 | $97M | +$145.2M |
| Q4 2025 | $238.1M | +$345.1M |
| Q3 2025 | -$104.3M | -$4.3M |
| Q2 2025 | $6.9M | +$131.8M |
| Q1 2025 | -$48.2M | -164% |
| Q4 2024 | -$107M | +$4.4M |
MTH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -1M shares |
| 1 year | -8.5% | -6.1M shares |
| 3 years | -12% | -9M shares |
| 5 years | -15% | -11.3M shares |
| Available history | -16% | -12.7M shares |
MTH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $55M |
| Q2 2026 | $100M |
| Q1 2026 | $130M |
| Q4 2025 | $150M |
| Q3 2025 | $55M |
| Q2 2025 | $45M |
| Q1 2025 | $45M |
| Q4 2024 | $40M |
MTH spent $435M buying back its own shares over the past year, up 135% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MTH on leverage, with a lower net debt burden relative to earnings.
MTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.6x | Very low |
MTH's net debt is about 2.8 years of its operating earnings (EBITDA), up from 1.5 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 46.3 | Neutral |
MTH's weekly RSI is 46 (neutral) and its Stochastic is 46 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MTH PE vs Consumer Cyclical Sector
| Metric | MTH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 98 | 47 | 51 pts above |
MTH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MTH on trend strength, trading above more of its moving averages.
MTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.5 | 2% above |
| 20 week MA | $68.4 | 5.3% below |
| 50 week MA | $69.1 | 6.2% below |
| 100 week MA | $70.4 | 7.9% below |
| 200 week MA | $73.4 | 12% below |
MTH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 12% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MTH on returns for 2026, with the stronger performance.
MTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.7 | $44.2 | +44% |
| 2021 | $44.2 | $58.5 | +32% |
| 2022 | $58.5 | $46.1 | -21% |
| 2023 | $46.1 | $87.1 | +89% |
| 2024 | $87.1 | $77.1 | -12% |
| 2025 | $77.1 | $66.8 | -13% |
| 2026 YTD | $66.8 | $64.8 | -3% |
MTH has finished lower in three of the last six years. It's down 3% so far in 2026.